Panel and Discussion with Fred Hutch Leaders In-Person
We’re in an era of both amazing scientific breakthroughs and immense health care challenges and opportunities. Join us for a conversation about the newest advances in cancer research and care — and what’s on the horizon — with three leaders from Fred Hutch Cancer Center in Seattle who are making those leaps possible.
Learn how discoveries are being transformed into ever-more personalized and effective cancer care as part of Fred Hutch’s pursuit of healthier lives for every person in every community.
Come curious — there will be plenty of time for Q&A.
This program will be livestreamed and recorded for later viewing. Click here to watch online.
Panelists will include Thomas J. Lynch Jr., MD, President and Director and Raisbeck Endowed Chair; Bruce Clurman, MD, PhD, Executive Vice President, Chief Scientific Officer and Deputy Director, and Rosput Reynolds Endowed Chair; and Sara Hurvitz, MD, Senior Vice President and Director of the Clinical Research Division.
- Date:
- Wednesday, July 17, 2024
- Time:
- 10:30am - 12:00pm
- Time Zone:
- Mountain Time - US & Canada (change)
- Location:
- John A. and Carole O. Moran Lecture Hall
- Campus:
- The Community Library
- Audience:
- Adults
- Categories:
- Lectures & Conversations
Thomas J. Lynch Jr., MD
President and Director and Raisbeck Endowed Chair
Dr. Lynch is a world-renowned scientist with expertise in solid tumor research, precision medicine, and fundamental biology. He is also a respected oncologist who has led top U.S. cancer centers for more than three decades. Dr. Lynch is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer.
Bruce Clurman, MD, PhD
Executive Vice President, Chief Scientific Officer and Deputy Director, and Rosput Reynolds Endowed Chair
Over three decades at Fred Hutch, Dr. Clurman has been a renowned laboratory scientist and international leader in understanding cell division and protein degradation pathways in cancer development and treatment. He is also a medical oncologist specializing in bone marrow transplantation. As chief scientific officer and deputy director, Dr. Clurman has major roles in developing and executing Fred Hutch’s research strategy. He is a member of the Association of American Physicians, the American Society for Clinical Investigation, the American Association for Cancer Research, and the American Society of Hematology.
Sara Hurvitz, MD
Senior Vice President and Director of the Clinical Research Division
Dr. Hurvitz is a medical oncologist, international expert in breast oncology, and leader in clinical and laboratory-based cancer research. She joined Fred Hutch from UCLA in 2023, bringing her extensive experience leading clinical trials. She is currently focused on expanding the clinical research programs for oncology and hematology. Dr. Hurvitz is a member of the American College of Physicians, the American Society of Hematology, the American Society of Clinical Oncology, American Association for Cancer Research, the European Society of Medical Oncology, and the American College of Physicians.
